{
  "meta": {
    "id": "test67",
    "title": "Heart Failure",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "Which is not a common feature of right heart failure?",
      "options": [
        {
          "label": "A",
          "text": "Raised JVP",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pulmonary oedema",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pitting pedal oedema",
          "correct": false
        },
        {
          "label": "D",
          "text": "Ascites",
          "correct": false
        }
      ],
      "correct_answer": "B. Pulmonary oedema",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Pulmonary oedema Pulmonary oedema due to left- sided heart failure presents with dyspnea and inspiratory crepitations over the lung bases . In contrast, right heart failure produces a high JVP with hepatic congestion and dependent peripheral oedema.</p>\n<p><strong>Highyeild:</strong></p><p>Symptoms Signs Dyspnea Elevated jugular venous pressure PND Hepatojugular reflux Orthopnea Third heart sound Fatigue Laterally shifted cardiac apical impulse Palpitations Dependent edema Dependent edema Basal crepitation Cachexia Tender hepatomegaly</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A: The jugular venous pressure (JVP) is usually elevated, particularly with associated fluid overload or right heart failure. Option: C: Dependent peripheral pitting oedema. Option: D: Ascites, a late sign, occurs as a consequence of increased pressure in the hepatic veins and the veins draining the peritoneum.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "73246f68",
      "audio": ""
    },
    {
      "text": "Which investigation is now considered gold standard for accessing LV mass and volumes in HF?",
      "options": [
        {
          "label": "A",
          "text": "Echocardiogram",
          "correct": false
        },
        {
          "label": "B",
          "text": "MRI",
          "correct": true
        },
        {
          "label": "C",
          "text": "ECG",
          "correct": false
        },
        {
          "label": "D",
          "text": "Chest radiograph",
          "correct": false
        }
      ],
      "correct_answer": "B. MRI",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>MRI Magnetic resonance imaging (MRI) also provides a comprehensive analysis of cardiac anatomy and function and is now the gold standard for assessing LV mass and volumes. MRI is also emerging as a useful and accurate imaging modality for evaluating patients with HF, both in terms of assessing LV structure and for determining the cause of HF (e.g., amyloidosis, ischemic cardiomyopathy, hemochromatosis).</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A: provide a semiquantitative assessment of LV size and function as well as the presence or absence of valvular and/or regional wall motion abnormalities. Option C: The major importance of the ECG is to assess cardiac rhythm and determine the presence of LV hypertrophy or a prior MI. Option D: A chest x-ray provides useful information about cardiac size and shape, as well as the state of the pulmonary vasculature, and may identify non cardiac causes of the patient\u2019s symptoms.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0266903c",
      "audio": ""
    },
    {
      "text": "The combination Sacubitril and valsartan, is now recommended in the management of resistant heart failure. Here, Sacubitril is",
      "options": [
        {
          "label": "A",
          "text": "Vasodilator",
          "correct": false
        },
        {
          "label": "B",
          "text": "Neprilysin inhibitor",
          "correct": true
        },
        {
          "label": "C",
          "text": "Angiotensin receptor blocker",
          "correct": false
        },
        {
          "label": "D",
          "text": "ACE inhibitor",
          "correct": false
        }
      ],
      "correct_answer": "B. Neprilysin inhibitor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Vasodilator Sacubitril, a small-molecule inhibitor of Neprilysin is used in combination with the ARB valsartan (Sacubitril\u2013valsartan), it has been shown to produce additional symptomatic and mortality benefit over ACE inhibition and is now recommended in the management of resistant heart failure.</p>\n<p><strong>Highyeild:</strong></p><p>Action Effect Sit the patient up Reduces preload Give high-flow oxygen Corrects hypoxia Ensure continuous positive airway pressure (CPAP) of 5-10 mmHg by tight-fitting mask Reduces preload and pulmonary capillary hydraulic gradient Administer nitrates:\" IV glyceryl trinitrate (10-200 \u00b5g/min) Buccal glyceryl trinitrate 2-5 mg Reduces preload and afterload Administer a loop diuretic: Furosemide (50-100 mg M Combats fluid overload</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: A: Venodilators, such as nitrates, reduce preload, and arterial dilators, such as hydralazine, reduce afterload. Option: C, D:</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f8b50079",
      "audio": ""
    },
    {
      "text": "Heart failure occurs when the heart muscle doesn't pump blood as well as it should. Blood often backs up and causes fluid to build up in the lungs (congestive) and in the legs. The fluid buildup can cause shortness of breath and swelling of the legs and feet. Poor blood flow may cause the skin to appear blue. Which of the following is most widely used criteria for diagnosing heart failure?",
      "options": [
        {
          "label": "A",
          "text": "Framingham criteria",
          "correct": true
        },
        {
          "label": "B",
          "text": "Boston criteria",
          "correct": false
        },
        {
          "label": "C",
          "text": "NHANES criteria",
          "correct": false
        },
        {
          "label": "D",
          "text": "Nadas\u2019 criteria",
          "correct": false
        }
      ],
      "correct_answer": "A. Framingham criteria",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Boston criteria Three diagnostic schemes for diagnosing heart failure are the Framingham, Boston, and NHANES criteria . The Framingham criteria are one of the most widely used criteria for diagnosing heart failure, requiring either two major or one major criteria and two minor criteria.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option: B, C: Less commonly used. Option: D: Used for congenital heart disease</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0585779b",
      "audio": ""
    },
    {
      "text": "Hepatojugular reflux, as presently defined, consists of a distention of the neck veins when pressure is applied over the liver. Positive hepatojugular reflux is found in:",
      "options": [
        {
          "label": "A",
          "text": "Mitral regurgitation",
          "correct": false
        },
        {
          "label": "B",
          "text": "Right heart failure",
          "correct": true
        },
        {
          "label": "C",
          "text": "Decreased after load",
          "correct": false
        },
        {
          "label": "D",
          "text": "Increased pulmonary capillary wedge pressure",
          "correct": false
        }
      ],
      "correct_answer": "B. Right heart failure",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Decreased after load In patients suspected of having right ventricular failure who have a normal CVP at rest, the abdominojugular reflux test may be helpful. The palm of the examiner's hand is placed over the abdomen, and firm pressure is applied for >15 seconds . In normal people, this maneuver does not alter the jugular venous pressure significantly, but when right heart function is impaired, the upper level of venous pulsation usually increases. A positive response is defined by a sustained rise of >3cm in JVP during application of firm abdominal pressure.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A : MR is not associated with positive HJ reflux. Option C : decreased afterload has nothing to do with HJ reflux. Option D :  Increased capillary wedge pressure indicates increase LA pressure</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c29bc335",
      "audio": ""
    },
    {
      "text": "Medicines are the main treatment for heart failure, but for some people surgery may help. Operations that can help with heart failure include: heart valve surgery. a coronary angioplasty or bypass. Which of the following is used in the treatment of CHF ?",
      "options": [
        {
          "label": "A",
          "text": "Vitamin B12B",
          "correct": false
        },
        {
          "label": "B",
          "text": "Vitamin B2",
          "correct": false
        },
        {
          "label": "C",
          "text": "Coenzyme Q",
          "correct": true
        },
        {
          "label": "D",
          "text": "None of the above",
          "correct": false
        }
      ],
      "correct_answer": "C. Coenzyme Q",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>It is used in the management of CHF. So, Option A, b and D are not used in the treatment of CHF.</p>\n<p><strong>Extraedge:</strong></p><p>New drugs in the management of CHF :- 1. Eplerenone ( an aldosterone receptor blocker)  is a potassium-sparing diuretic, just like spironolactone, but it does not cause gynecomastia. 2. Nesiritide (vasodilation) (BNP analogue): so it causes natriuresis. 3. Levosimendan, used for the treatment of acute and decompensated CHF, exerts potent positive inotropic action and peripheral vasodilatory effects. 4. Coenzyme Q is a universal antioxidant drug, improves diastolic volume and ejection fraction in CHF patients. 5. Hydralazine and isosorbide dinitrate 6. Istaroxime: It is a positive inotropic agent that mediates its action through inhibition of Na+/K+ ATPase. 7. Sildenafil : It is Phosphodiesterase-5 inhibitor, mainly for PAH, increases NO, increasing C \u2013 GNP (muscle relaxation). 8. Omecamtiv & Mecarbil: these are selective myosin activators. They prolong the ejection period and increase fractional shortening. 9. Serelaxin: It is a Vasodilator.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3a8416da",
      "audio": ""
    },
    {
      "text": "A rate less than 50 beats per minute may be a more pragmatic definition, as most patients with sinus rates in the 50s are asymptomatic. It is important to note that the rate at which a patient is labelled as having bradycardia is somewhat age-dependent. The Treatment of asymptomatic bradycardia is:",
      "options": [
        {
          "label": "A",
          "text": "No treatment is required",
          "correct": true
        },
        {
          "label": "B",
          "text": "Give atropine",
          "correct": false
        },
        {
          "label": "C",
          "text": "Isoprenaline",
          "correct": false
        },
        {
          "label": "D",
          "text": "Cardiac pacing",
          "correct": false
        }
      ],
      "correct_answer": "A. No treatment is required",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>No treatment is required Asymptomatic bradycardia requires no treatment . But patients with bradycardia with symptoms (fatigue, dizziness) should be treated by injection astrophine, or injection isoprenaline or pacemaker. So , Option B , C, and D are not the correct treatment in this case.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4afca29e",
      "audio": ""
    },
    {
      "text": "A 62-year-old male, known to hypertensive on medications, presents with worsening dyspnea on exertion for 6 months. On examination, there is elevated JVP, positive abdominojugular reflux, and bilateral pitting pedal edema. Shifting dullness is elicited on abdominal examination. On auscultation, bibasal crepitations are heard. What is the probable cause for the signs and symptoms seen in this patient?",
      "options": [
        {
          "label": "A",
          "text": "Right Heart Failure",
          "correct": false
        },
        {
          "label": "B",
          "text": "Left Heart Failure",
          "correct": false
        },
        {
          "label": "C",
          "text": "Biventricular failure",
          "correct": true
        },
        {
          "label": "D",
          "text": "Portal Hypertension",
          "correct": false
        }
      ],
      "correct_answer": "C. Biventricular failure",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Biventricular failure</p>\n<p><strong>Highyeild:</strong></p><p>Right Heart Failure => Due to systemic Congestion Left Heart Failure => Due to pulmonary congestion 1. Raised JVP (earliest 1. Dyspnea on exertion 2. Positive Hepatojugular Reflux 2. Orthopnea 3. Ascites 3. Bibasal crepts 4. Congestive hepatomegaly 5. Fatigue As we can see, the patient has features of both RHF and LHF, hence it is a case of biventricular failure. Portal Hypertension (option d) presents with ascites and splenomegaly, but there is usually no dyspnea, unless there are massive ascites pressing on the diaphragm.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f4f2c4fc",
      "audio": ""
    },
    {
      "text": "A 70-year-old male, known to be hypertensive on medications, presents with worsening dyspnea on exertion for 6 months. On examination, there is elevated JVP, positive abdominojugular reflux, and bilateral pitting pedal edema. Shifting dullness is elicited on abdominal examination. On auscultation, bibasal crepitations are heard. Echocardiography shows LVEF 35%. Which of the following statements is incorrect regarding his condition?",
      "options": [
        {
          "label": "A",
          "text": "BNP values may be falsely low in this patient",
          "correct": true
        },
        {
          "label": "B",
          "text": "Beta blockers may be used in this patient",
          "correct": false
        },
        {
          "label": "C",
          "text": "The patient has heart failure with reduced ejection fraction",
          "correct": false
        },
        {
          "label": "D",
          "text": "Soluble ST-2 is a new marker used for determining prognosis of this condition",
          "correct": false
        }
      ],
      "correct_answer": "A. BNP values may be falsely low in this patient",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>BNP values may be falsely low in this patient BNP is a natriuretic peptide secreted by the ventricular myocytes in response to volume overload, which causes natriuresis, diuresis and vasodilation thereby acting against this volume overload. In this patient presenting with classical signs of heart failure, BNP (or NT proBNP) is expected to be elevated. However, in advanced age, there is a chance of false increase in BNP ( as opposed to decrease in option a).</p>\n<p><strong>Highyeild:</strong></p><p>BNP falsely low BNP falsely high \u2756    Flash pulmonary edema \u2756    -Advanced age \u2756    Obese patients \u2756    -Renal impairment \u2756    -Female patients \u2756    Patients on ARNI</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option B: Beta blockers, along with ACEI, are the treatment of choice in patients with HFrEFafter achieving euvolemic status with diuretics Option C: HFFEF: EF < 40% (35% in this case) HFmrEF: EF 40- 50% HFPEF: EF >50% Option D: Soluble ST 2 is a new prognostic marker used in heart failure. Galectin 3 is anothernewer marker</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "8309b47d",
      "audio": ""
    },
    {
      "text": "Which of the following is a selective myosin activator used in heart failure?",
      "options": [
        {
          "label": "A",
          "text": "Vericiguat",
          "correct": false
        },
        {
          "label": "B",
          "text": "Dapagliflozin",
          "correct": false
        },
        {
          "label": "C",
          "text": "Gemtuzumab ozogamicin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Omecamtiv mecarbil",
          "correct": true
        }
      ],
      "correct_answer": "D. Omecamtiv mecarbil",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Omecamtiv mecarbil Omecamtiv is a selective myosin activator recently approved for the treatment of HFrEF. It acts by prolonging ejection period and increasing fractional shortening without altering force of contraction . There, unlike inotropes, it increases cardiac output without increasing myocardial oxygen demand. It is available as an oral formulation</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options:- Option A -Vericiguat is an oral-soluble guanylyl cyclase stimulator used in HFrEF. Option b -Dapagliflozin is a SGLT-2 inhibitor approved for use in HFrEF and shows significant reduction in mortality independent of HbA1c reduction. It has shown to increase risk of lower limb fracture, peripheral arterial disease, and amputations of prolonged use. Option C- Gemtuzumab (ozogamicin) is an anti-CD33 antibody used in the treatment of AML</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "5e3f4a97",
      "audio": ""
    },
    {
      "text": "Mr. X, a known case of HFrEF on ARNI, presents to the ER with sudden onset worsening of dyspnea over last few hours. His vitals are as follows: BP = 110/70 PR = 110 SpO2 = 92% on room air On examination, JVP is raised, and bibasal crepitations are heard. Bipedal pitting edema is also present. As an intern in the emergency department, what will be your initial management style?",
      "options": [
        {
          "label": "A",
          "text": "Start with oxygen through a face mask and nebulize with salbutamol",
          "correct": false
        },
        {
          "label": "B",
          "text": "Start oxygen with a face mask and give an injection of furosemide",
          "correct": true
        },
        {
          "label": "C",
          "text": "Give digoxin",
          "correct": false
        },
        {
          "label": "D",
          "text": "Add beta blockers to his daily medications",
          "correct": false
        }
      ],
      "correct_answer": "B. Start oxygen with a face mask and give an injection of furosemide",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Solution:</strong></p><p>Start oxygen with a face mask and give an injection of furosemide This patient has a warm wet type of acute decompensated heart failure, as his blood pressure and perfusion are maintained with more of volume overload symptoms. In this case, therapy of choice is a diuretic like furosemide with moist oxygen to maintain saturation if required.</p>\n<p><strong>Random:</strong></p><p>Explanation for incorrect options: - Option A : Salbutamol nebulisation is indicated in acute asthma. Patients will have bilateral diffuse polyphonic wheezing instead of crepitations. Option C: Digoxin is never indicated as first line therapy in heart failure. It is relegated to late line therapy in patients who remain symptomatic despite adequate neurohormonal therapy and volume control. Option D: Beta blockers are contraindicated in decompensated heart failure.</p>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "d2b3a5c6",
      "audio": ""
    }
  ]
}